SyneuRx International (Taiwan) Corp

NEUSERINE

Therapeutic pharmaceutical for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; chemical preparations for pharmaceutical or medical purposes, namely, for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; chemical reagents for medical or veterinary purposes, excluding reagents for use in development of skin care products or cosmetics; antibacterial substances for medical purposes, excluding antibacterial substances for use in skin care products or cosmetics; amino acid preparations for medical purposes, excluding amino acid preparations for use in skin care products or cosmetics; amino acids for medical or veterinary purposes, excluding amino acids for use in skin care products or cosmetics; amino acids for medical purposes, excluding amino acids for use in skin care products or cosmetics;

SYNSERIN

Therapeutic pharmaceutical for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Chemical reagents for medical or veterinary purposes; Antibacterial substances for medical purposes; Amino acid preparations for medical purposes; Amino acids for medical or veterinary purposes; Amino acids for medical purposes;

SYNXYRIN

Therapeutic pharmaceutical for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Chemical reagents for medical or veterinary purposes; Antibacterial substances for medical purposes; Amino acid preparations for medical purposes; Amino acids for medical or veterinary purposes; Amino acids for medical purposes;